1. Home
  2. NNDM vs IMMX Comparison

NNDM vs IMMX Comparison

Compare NNDM & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.77

Market Cap

368.1M

Sector

Technology

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$5.95

Market Cap

306.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNDM
IMMX
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.1M
306.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NNDM
IMMX
Price
$1.77
$5.95
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
2.6M
1.0M
Earning Date
11-19-2025
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,663,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
26.75
N/A
52 Week Low
$1.31
$1.34
52 Week High
$2.69
$7.73

Technical Indicators

Market Signals
Indicator
NNDM
IMMX
Relative Strength Index (RSI) 48.01 58.59
Support Level $1.77 $5.73
Resistance Level $1.97 $6.49
Average True Range (ATR) 0.10 0.48
MACD -0.01 0.09
Stochastic Oscillator 26.42 74.34

Price Performance

Historical Comparison
NNDM
IMMX

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: